Channick R - Search Results

1

Selexipag for the Treatment of Pulmonary Arterial Hypertension.

Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV; GRIPHON Investigators. Sitbon O, et al. Among authors: channick r. N Engl J Med. 2015 Dec 24;373(26):2522-33. doi: 10.1056/NEJMoa1503184. N Engl J Med. 2015. PMID: 26699168 Free article. Clinical Trial.

2

Chronic thromboembolic pulmonary hypertension.

Fedullo PF, Auger WR, Channick RN, Moser KM, Jamieson SW. Fedullo PF, et al. Among authors: channick rn. Clin Chest Med. 1995 Jun;16(2):353-74. Clin Chest Med. 1995. PMID: 7656546 Review.

3

Combination therapy for pulmonary hypertension: a glimpse into the future?

Channick RN, Rubin LJ. Channick RN, et al. Crit Care Med. 2000 Mar;28(3):896-7. doi: 10.1097/00003246-200003000-00055. Crit Care Med. 2000. PMID: 10752856 No abstract available.

4

The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy.

Kerr KM, Auger WR, Marsh JJ, Comito RM, Fedullo RL, Smits GJ, Kapelanski DP, Fedullo PF, Channick RN, Jamieson SW, Moser KM. Kerr KM, et al. Among authors: channick rn. Am J Respir Crit Care Med. 2000 Jul;162(1):14-20. doi: 10.1164/ajrccm.162.1.9712142. Am J Respir Crit Care Med. 2000. PMID: 10903213 Clinical Trial.

5

"High probability" perfusion lung scans in pulmonary venoocclusive disease.

Bailey CL, Channick RN, Auger WR, Fedullo PF, Kerr KM, Yung GL, Rubin LJ. Bailey CL, et al. Among authors: channick rn. Am J Respir Crit Care Med. 2000 Nov;162(5):1974-8. doi: 10.1164/ajrccm.162.5.2003045. Am J Respir Crit Care Med. 2000. PMID: 11069842

6

A new era in the treatment of primary pulmonary hypertension.

Bailey CL, Channick RN, Rubin LJ. Bailey CL, et al. Among authors: channick rn. Heart. 2001 Mar;85(3):251-2. doi: 10.1136/heart.85.3.251. Heart. 2001. PMID: 11179256 Free PMC article. No abstract available.

7

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study.

Channick R, Badesch DB, Tapson VF, Simonneau G, Robbins I, Frost A, Roux S, Rainisio M, Bodin F, Rubin LJ. Channick R, et al. J Heart Lung Transplant. 2001 Feb;20(2):262-263. doi: 10.1016/s1053-2498(00)00606-9. J Heart Lung Transplant. 2001. PMID: 11250530 No abstract available.

8

Pulmonary vasoreactivity in PPH.

Robbins IM, Barst RJ, Channick RN, Rubin LJ. Robbins IM, et al. Among authors: channick rn. J Am Coll Cardiol. 2001 Oct;38(4):1267-8. doi: 10.1016/s0735-1097(01)01527-3. J Am Coll Cardiol. 2001. PMID: 11587028 Free article. No abstract available.

9

New and experimental therapies for pulmonary hypertension.

Channick RN, Rubin LJ. Channick RN, et al. Clin Chest Med. 2001 Sep;22(3):539-45. doi: 10.1016/s0272-5231(05)70290-2. Clin Chest Med. 2001. PMID: 11590847 Review.

10

Chronic thromboembolic pulmonary hypertension.

Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. Fedullo PF, et al. Among authors: channick rn. Clin Chest Med. 2001 Sep;22(3):561-81. doi: 10.1016/s0272-5231(05)70292-6. Clin Chest Med. 2001. PMID: 11590849 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page